China Isotope & Radiation Corp
HKEX:1763
P/B
Price to Book Value
Price to Book Value (P/B) ratio is a valuation multiple that measures the market's valuation of a company relative to its book value. The P/B ratio is only considered useful in practice when applied to capital-intensive businesses.
Market Cap | P/B | ||||
---|---|---|---|---|---|
CN |
C
|
China Isotope & Radiation Corp
HKEX:1763
|
3.5B HKD | 0.7 | |
JP |
Hoya Corp
TSE:7741
|
6.4T JPY | 7.3 | ||
CH |
Alcon AG
SIX:ALC
|
35.7B CHF | 1.9 | ||
DK |
Coloplast A/S
CSE:COLO B
|
193.7B DKK | 12.8 | ||
US |
Align Technology Inc
NASDAQ:ALGN
|
23.2B USD | 6.4 | ||
US |
Cooper Companies Inc
NYSE:COO
|
17.8B USD | 2.3 | ||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
14.2T KRW | 27.1 | |
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
56.8B CNY | 7.5 | ||
UK |
ConvaTec Group PLC
LSE:CTEC
|
5.3B GBP | 3.9 | ||
US |
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
6.4B USD | 1.9 | ||
CA |
B
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.2B USD | 0.8 |
P/B Forward Multiples
Forward P/B multiple is a version of the P/B ratio that uses forecasted equity for the P/B calculation. 1-Year, 2-Years, and 3-Years forwards use equity forecasts for 1, 2, and 3 years ahead, respectively.